| Entry |
|
|---|
| Name |
Relatlimab (USAN) |
|---|
| Formula |
C6472H9922N1710O2024S38
|
|---|
| Exact mass |
145197.5424
|
|---|
| Mol weight |
145286.80
|
|---|
| Class |
Antineoplastic
DG02938 Immune checkpoint inhibitor
|
|---|
| Remark |
| Product (mixture): | D12334<US> |
|
|---|
| Efficacy |
Antineoplastic, Immune checkpoint inhibitor |
|---|
| Type |
Monoclonal antibody |
|---|
| Target |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG02938 Immune checkpoint inhibitor
D11350 Relatlimab
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Other cell surface molecules
Immune checkpoints
LAG3 (CD223)
D11350 Relatlimab (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
